Back

Promedica International

  • Atherosclerosis
  • Coronary Artery Disease

Controversies & Advances in the Treatment of Cardiovascular Disease, the Twenty-Fourth in the Series

Controversies 2027 is an accredited education program that will deliver expert insights and dynamic discussions on the most pressing controversies in cardiovascular medicine. Through engaging keynote presentations, spirited debates, and interactive panel discussions, thought leaders will address cutting-edge topics in coronary artery disease, structural heart interventions, atherosclerosis, electrophysiology, imaging, hypertension, AI in healthcare, and groundbreaking clinical trials that are reshaping practice. Join us for evidence-based perspectives and real-world applications that will enhance your clinical decision-making.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 16 credits

MOC types

ABIM — Medical KnowledgeUp to 16 pointsABIM — Patient SafetyUp to 16 points

FDA REMS

No

Qualifies for MIPS

No
Start Date
January 21, 2027
End Date
January 23, 2027
  • Live
  • Credit · Up to 16 credits
  • MOC · Up to 16 points
  • Paid · fee on provider site
  • When
    Jan 21–22, 2027